These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8407274)

  • 1. Lyme disease acquired in Israel: report of a case and studies of serological cross reactivity in relapsing fever.
    Berger SA; Samish M; Kletter Y; Tinghitella T; Heering S; Edberg SC
    Isr J Med Sci; 1993 Aug; 29(8):464-5. PubMed ID: 8407274
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapsing fever and its serological discrimination from Lyme borreliosis.
    Rath PM; Rögler G; Schönberg A; Pohle HD; Fehrenbach FJ
    Infection; 1992; 20(5):283-6. PubMed ID: 1385332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Focus of borreliosis in Gisenyi (Rwanda)].
    Malatre I; Giocanti R; Macaigne F; Ripert C
    Med Trop (Mars); 1991; 51(1):49-52. PubMed ID: 2072849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3M Fast-Lyme test in the diagnosis of Lyme disease in Poland].
    Knap J; Raczka A; Anusz Z; Bartoszcze M; Mierzejewski J; Dabrowski Z
    Pneumonol Alergol Pol; 1991; 59 Suppl 1():69-74. PubMed ID: 1843814
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-reaction between Yersinia outer membrane proteins and anti-Borrelia antibodies in sera of patients with Lyme disease.
    Golkocheva-Markova E; Christova I; Stoilov R; Najdenski H
    Clin Microbiol Infect; 2008 Sep; 14(9):873-5. PubMed ID: 18844689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk of human infection with Ixodes tick-borne relapsing fever in different regional subzones of the Perm region].
    Alypova II; Korenberg EI; Vorob'eva NN
    Med Parazitol (Mosk); 2002; (1):37-40. PubMed ID: 12224266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of vectors for Borrelia burgdorferi and Lyme seropositivity in Sivas region].
    Güneş T; Poyraz O; Kaya S; Gençer L; Alim A
    Mikrobiyol Bul; 2005 Oct; 39(4):503-8. PubMed ID: 16544552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of relapsing fever borreliosis in Europe.
    Rebaudet S; Parola P
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):11-5. PubMed ID: 16965346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case control study: Serological evidence that Borrelia miyamotoi disease occurs nationwide in Japan.
    Sato K; Sakakibara K; Masuzawa T; Ohnishi M; Kawabata H
    J Infect Chemother; 2018 Oct; 24(10):828-833. PubMed ID: 30057339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of serum specific antibodies to Borrelia burgdorferi antigens in persons from region of high risk of tick bites.
    Kowal K
    Pneumonol Alergol Pol; 1992; 60 Suppl 1():67-70. PubMed ID: 1292851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of cross reactions using serological techniques between Borrelia burgdorferi and Treponema pallidum].
    Artero JM; Mellado M; Martín Luengo F
    Enferm Infecc Microbiol Clin; 1991 Feb; 9(2):127-8. PubMed ID: 1854844
    [No Abstract]   [Full Text] [Related]  

  • 14. Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.
    Koetsveld J; Platonov AE; Kuleshov K; Wagemakers A; Hoornstra D; Ang W; Szekeres S; van Duijvendijk GLA; Fikrig E; Embers ME; Sprong H; Hovius JW
    Clin Microbiol Infect; 2020 Apr; 26(4):513.e1-513.e6. PubMed ID: 31404672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borrelia burgdorferi (strain B. afzelii) antibodies among Malaysian blood donors and patients.
    Tay ST; Kamalanathan M; Rohani MY
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):787-93. PubMed ID: 12757227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification and initial results of the study of Lyme disease in northwestern USSR].
    Korenberg EI; Kovalevskiĭ IuV; Kuznetsova RI; Fonarev LS; Churilova AA
    Med Parazitol (Mosk); 1988; (1):45-8. PubMed ID: 2966893
    [No Abstract]   [Full Text] [Related]  

  • 17. The versatile roles of antibodies in Borrelia infections.
    Connolly SE; Benach JL
    Nat Rev Microbiol; 2005 May; 3(5):411-20. PubMed ID: 15864264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The important and diverse roles of antibodies in the host response to Borrelia infections.
    LaRocca TJ; Benach JL
    Curr Top Microbiol Immunol; 2008; 319():63-103. PubMed ID: 18080415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attempt at detecting strain differences in the causative agent of tick-borne relapsing fever].
    Kriuchechnikov VN; Korenberg EI; Shcherbakov SV
    Med Parazitol (Mosk); 1982; 51(4):74-9. PubMed ID: 6215570
    [No Abstract]   [Full Text] [Related]  

  • 20. IgE anti-Borrelia burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with Lyme disease.
    Bluth MH; Robin J; Ruditsky M; Norowitz KB; Chice S; Pytlak E; Nowakowski M; Durkin HG; Smith-Norowitz TA
    Scand J Immunol; 2007 Apr; 65(4):376-82. PubMed ID: 17386029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.